Abstract
Chapters 11 through 14 have set forth in some detail the functional changes induced by anticholinesterase (anti-ChE) agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature
Aeschlimann, J. A., and M. Reinert: The pharmacological action of some analogues of physostigmine. J. Pharmacol. exp. Ther. 43, 413–444 (1931).
Axopyan, N. E., and V. M. Samvxlyan: Relationship between local anesthetic, cholinolytic and anticholinesterase activity of benzoic acid esters (in Russian). Farmakol. i Toksikol. 21, No. 5, 38–42 (1958).
Altschule, M. D., and A. Iglauer: The effect of benzedrine and paredrine on the circulation, metabolism and respiration in normal man. J. clin. Invest. 19, 497–502 (1940).
Ambache, N.: The peripheral action of Clostridium botulinum toxin. J. Physiol. (Lond.) 108, 127–141 (1949).
Arnow, L. E.: Colorimetric determination of the components of 3,4-dihydroxyphenylalaninetyrosine mixtures. J. biol. Chem. 118, 531–537 (1937).
Askew, B. M.: Oximes and hydroxamic acids as antidotes in anticholinesterase poisoning Brit. J. Pharmacol. 11, 417–423 (1956).
Askew, B. M.: Oximes and atropine in sarin poisoning. Brit. J. Pharmacol. 12, 340–343 (1957).
Atanacrovic, D., and S. Dalgaard-Mikrelsen: Contributions à la pharmacologie de la procaine. Arch. int. Pharmacodyn. 85, 1–16 (1951).
Augustinsson, K.-B.: Reaction of organophosphorus compounds with dihydroxyphenyl derivatives. Acta chem. scand. 6, 959–961 (1952).
Augustinsson, K.-B.: Enzyme studies with diethyl-p-nitrophenylphosphate (Mintacol). Acta pharmacol. (Kbh.) 9, 245–252 (1953a).
Augustinsson, K.-B.: Biochemical studies with tabun and allied compounds. Ark. Kemi. 6, 331–350 (1953b).
Augustinsson, K.-B., and M. Grahn: Protection of cholinesterases by procaine against inactivation by tabun in vitro. Acta physiol. scand. 27, 10–17 (1952).
Augustinsson, K.-B., and D. Nachmansorn: Studies on cholinesterase. VI. Kinetics of the inhibition of acetylcholine esterase. J. biol. Chem. 179, 543–559 (1949).
Austin, L., and D. R. Davies: The part played by inhibition of cholinesterases of the CNS in producing paralysis in chickens. Brit. J. Pharmacol. 9, 145–152 (1954).
Balotin, N. M., and J. M. Coon: The antagonism of some actions of TEPP by morin. Arch. int. Pharmacodyn. 123, 395–405 (1960).
Barnes, J. M.: The reactions of rabbits to poisoning by p-nitrophenyldiethylphosphate (E600). Brit. J. Pharmacol. 8, 208–211 (1953).
Barnes, J. M., and F. A. Denz: Experimental demyelination with organophosphorus compounds. J. Path. Bact. 65, 597–605 (1953).
Bay, E.: Pharmacodynamics of 1,1’trimethylene bis (4-formylpyridinium bromide) dioxime (TMB-4). Fed. Proc. 18, 366 (1959).
Bay, E., S. Krop and L. F. Yates: Chemotherapeutic effectiveness of 1,1’-trimethylene bis (4formyl-pyridinium bromide) dioxime (TMB-4) in experimental anticholinesterase poisoning. Proc. Soc. exp. Biol. (N. Y.) 98, 107–110 (1958).
Bayliss, B. J., J. Elkes, S G Spanner and A. Todrick: The effect of DFP on the sensi-tivity of rats to centrally-acting drugs. Brit. J. Pharmacol. 12, 536–539 (1957).
Beiler, J. M., R. Brendel, M. Graff and G. J. Martin: Effect of vitamin P compounds on choline acetylase. Arch. Biochem. 26, 72–76 (1950).
Berry, W. K., K. P. Fellowes, P. J. Fraser, J. P. Rutland and A. Todrick: The in vitro protection of cholinesterases against some organophosphorus inhibitors. Biochem. J. 59, 1–5 (1955).
Bhattacharya, B. K.: Antispasmodic properties of certain quaternary derivatives of 2,2diphenyl-4-diisopropylamino-butyramide and other compounds in the isolated perfused guinea pig lung. Arch. int. Pharmacodyn. 104, 285–292 (1956).
Bhattacharya, B. K., and D. Atanackovic: On the pharmacology of procaine and its antagonists on the bronchial musculature. Arch. int. Pharmacodyn. 104, 275–284 (1956).
Bidstrup, P. L., J. A. Bonnell and A. G. Beckett: Paralysis following poisoning by a new organic phosphorus insecticide (mipafox): report on two cases. Brit. med. J. 19531, 1068–1072.
Blank, I. II., R. D. Griesemer and E. Gould: The penetration of an anticholinesterase agent (sarin) into skin. I. Rate of penetration into excised human skin. J. invest. Derm. 29, 299–309 (1957).
Blank, I. II., R. D. Griesemerand E. Gould: The penetration of an anticholinesterase agent (sarin) into skin. II. Autoradiographic studies. J. invest. Derm. 30, 187–191 (1958).
Bradley, P. B., S. Cerquigliniand J. Elkes: Some effects of diisopropylfluorophosphate on the electrical activity of the brain of the cat. J. Physiol. (Lond.) 121, 51P - 52P (1953).
Brooks, V. B.: The action of botulinum toxin on motor-nerve filaments. J. Physiol. (Lond.) 123, 501–515 (1954).
Brown, R. V.: The effects of intracisternal sarin and pyridine-2-aldoxime methyl methanesulfonate in anesthetized dogs. Brit. J. Pharmacol. 15, 170–174 (1960).
Bülbring, E., and J. H. Burn: Observations bearing on synaptic transmission by acetylcholine in the spinal cord. J. Physiol. (Lond.) 100, 337–368 (1941).
Burgen, A. S. V., F. Dickensand L. J. Zatman: The action of botulinum toxin on the neuromuscular junction. J. Physiol. (Lond.) 109, 10–24 (1949).
Burgen, A. S., C. A. Keele, M. Chennflls, J Delcastillo, W. F. Floyd, D. Slomeand S. Wright: Physiological effects of alkyl polyphosphates. Nature (Lond.) 160, 760–761 (1947).
Burgen, A. S., C. A. Keele, and D. Slome: Pharmacological actions of tetraethylpyrophosphate and hexaethyltetraphosphate. J. Pharmacol. exp. Ther. 96, 396 409 (1949).
Calma, I.: Observations on the action of prostigmine on the spinal cord of the cat. J. Physiol. (Lond.) 108, 282–291 (1949).
Candole, C. A. De, W. W. Douglas, C. L. Evans, R. Holmes, K. E. v. Spencer, R. W. Torranceand K. M. Wilson: The failure of respiration in death by anticholinesterase poisoning. Brit. J. Pharmacol. 8, 466 475 (1953).
Candole, C. A., and M. K. Mcphau,: Sarin and paraoxon antagonism in different species. Canad. J. Biochem. 35, 1071–1083 (1957).
Cavanagh, J. B., and R. H. S. Thompson: Demyelination. Brit. med. Bull. 10, 47–51 (1954).
Chasanov, M. G., and J. Epstein: Ion exchange resins as catalysts in the decomposition of sarin. J. Polym. Sci. 31, 399–414 (1958).
Childs, A. F., D. R. Davies, A. L. Greenand J. P. Rutland: The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organophosphorus compounds. Brit. J. Pharmacol. 10, 462–465 (1955).
Cohen, J. A., and C. H. Posthumus: The mechanism of action of anticholinesterases. Acta physiol. pharmacol. neerl. 4, 17–36 (1955).
Cohen, J. A., M. G. P. J. Warringaand B. R. Bovens: Protection of true cholinesterase against DFP by butyrylcholine. Biochim. biophys. Acta 6, 469–476 (1951).
Collomp, J.: Les trions. Bull. d’Inf. Tech. Sci. No. 23/G, 1 (1949).
Courtney, R. C., R. L. Gustafson, S. J. Westerback, H. Hyytiäinen, S. C. Chaberek, jr. and A. E. Martell: Metal chelate compounds as catalysts in the hydrolysis of isopropyl methylphosphonofluoridate and diisopropylphosphorofluoridate. J. A.er. chem. Soc. 79, 3030–3036 (1957).
Cullumbine, H., and P. Dirnhuber: Oral and bronchial fluids in poisoning with anticholinesterases. J. Pharm. (Lond.) 7, 580–585 (1955).
Dahlbom, R., H. Diamant, T. Edlund, T. Ekstrandand B. Holmstedt: Protective effect of phenothiazine derivatives against poisoning by the irreversible cholinesterase inhibitor dimethylamidoethoxy-phosphoryl cyanide (tabun). Acta pharmacol. (Kbh.) 9, 163–167 (1953).
Dale, H. H.: The action of certain esters and ethers of choline and their relation to muscarine. J. Pharmacol. 6, 147–190 (1914).
Davies, D. R., A. L. Greenand G. L. Willey: 2-hydroxyiminomethyl-N-methylpyridinium methanesulfonate and atropine in the treatment of severe organophosphate poisoning. Brit. J. Pharmacol. 14, 5–8 (1959).
Davison, A. N.: The conversion of schradan (OMPA) and parathion into inhibitors of cholinesterase by mammalian liver. Biochem. J. 61, 203–209 (1955).
Deburgh Daly, M.: The cardiovascular effects of anticholinesterases in the dog with special reference to hemodynamic changes in the pulmonary circulation. J. Physiol. (Lond.) 139, 250–272 (1957).
Deburgh Daly, M., and P. G. Wright: The effects of anticholinesterases upon peripheral vascular resistance in the dog. J. Physiol. (Lond.) 133, 475–497 (1956).
Desmedt, J. E.: Myasthenic-like features of neuromuscular transmission after administration of an inhibitor of acetylcholine synthesis. Nature (Lond.) 182, 1673–1674 (1958).
Diamant, H.: Cholinesterase inhibitors and vestibular function. Acta otolaryng. (Stockh.) Suppl. 111, 1–84 (1954).
Dirnhuber, P., and H. Cullumbine: The effect of anticholinesterase agents on the rat’s blood pressure. Brit. J. Pharmacol. 10, 12–15 (1955).
Distefano, V., L. Hubwitz, W. F. Neuman and H. C. Hodge: Coramine (Nikethamide) as adjuvant to atropine in treatment of poisoning by EPN. Proc. Soc. exp. Biol. (N. Y.) 78, 712–713 (1951).
Dixon, W. E., and T. G. Brodie: Contributions to the physiology of the lungs. I. The bronchial muscles, their innervation and the action of drugs upon them. J. Physiol. (Lond.) 29, 97–173 (1903).
Douglas, W. W., and P. B. C. Matthews: Acute tetraethylpyrophosphate poisoning in cats and its modification by atropine or hyoscine. J. Physiol. (Lond.) 116, 202–218 (1952).
Douglas, W.W., and W. D. M. Paton: The mechanisms of motor end-plate depolarization due to a cholinesterase-inhibiting drug. J. Physiol. (Lond.) 124, 325–344 (1954).
Dubois, K. P., J. Doull, P. R. Salernoand J. M. Coon: Studies on the toxicity and mechanism of action of p-nitrophenyl diethyl thionophosphate (parathion). J. Pharmacol. exp. Ther. 95, 79–91 (1949).
Dultz, L., M. A. Epstein, G. Freeman, E. H. Gray and W. B. Weil: Studies on a group of oximes as therapeutic compounds in sarin poisoning. J. Pharmacol. exp. Ther. 119, 522–531 (1957).
Durham, W. F., T. B. Gainesand W. J. Hayes, jr.: Paralytic and related effects of certain organic phosphorus compounds. Arch. industr. H1th. 13, 326–330 (1956).
Eccles, J. C., B. Katzand S. W. Kuffler: Effect of eserine on neuromuscular transmission. J. Neurophysiol. 5, 211–230 (1942).
Edery, H.: Effects of diacetyl monoxime on neuromuscular transmission. Brit. J. Pharmacol. 14, 317–322 (1959).
Edmunds, C. W., and G. F. Keiper: Further studies on the action of botulinus toxin. J. Amer. med. Ass. 83, 495–501 (1924).
Eickstedt, K.-W. Von, W.-D. ErdmannU. K.-P. Schaefer: Über die blutdrucksteigernde Wirkung von Esteraseblockern (E 605, eserin and prostigmin). Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 226, 435 441 (1955).
Emmelin, N., and F. C. Macintosh: The release of acetylcholine from perfused sympathetic ganglia and skeletal muscles. J. Physiol. (Lond.) 131, 477–496 (1956).
Epstein, J.: Nerve gas in public water. Publ. I-11th. Rep. 71, 955–962 (1956).
Epstein, J., M. M. Demexand D. H. Rosenblatt: Reaction of paraoxon with hydrogen peroxide in dilute aqueous solution. J. org. Chem. 21, 796–797 (1956).
Epstein, J., and D. H. Rosenblatt: Kinetics of some metal ion-catalyzed hydrolyses of isopropyl methylphosphonofluoridate (GB) at 25°. J. Amer. them. Soc. 80, 3596–3598 (1958).
Epstein, J., and D. H., and M. M. Demek: Kinetics of the reaction of isopropyl methylphosphonofluoridate with catechols at 25°. J. Amer. them. Soc. 78, 341–343 (1956).
Epstein, M. A., and G. Freeman: Toxicity of hydroxamic acid analogues: prophylactic and therapeutic efficacy against nerve gas poisoning in mice. Proc. Soc. exp. Biol. (N. Y.) 92, 660–662 (1956).
Erdmann, W.-D., F. Duensingu. K.-P. Schaeffer: Zentralnervöse: Irkungen von E 605 am Warmblüter. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 225, 114–115 (1955).
Erdmann, W.-D., H. D. Kempeu. W. Lühning: Über die Wirkung von Esteraseblockern (E605, Eserin and Prostigmin) auf das Atemzentrum von Katze and Hund. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 225, 359–368 (1955).
Erdmann, W.-D., and K. P. Schaefer: Über die Wirkung von Diäthylnitrophenylthiophosphat (E 605) auf Riickenmarksreflexe an der Katze. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 223, 519–532 (1954).
Essig, C. F., J. L. Hampson, P. D. Bales, A. Wirus and H. E. Himwich: Effect of panparnit on brain wave changes induced by diisopropyl fluorophosphate (DFP). Science 111, 38–39 (1950).
Evans, C. L.: Neuromuscular block by anticholinesterases. J. Physiol. (Lond.) 114, 6P (1951).
Farquharson, M. E., and R. G. Johnston: Antagonism of the effects of tremorine by tropine derivatives. Brit. J. Pharmacol. 14, 559–566 (1959).
Ferguson, R. L., and S. D. Silver: Demonstration in skin of active chlorine from chlorine-liberating ointments. Amer. J. clin. Path. 17, 35–36 (1947).
Fisher, R. A.: Statistical methods for research workers, 11th ed. Edinburgh: Oliver and Boyd (1950). Section 29.
Fleckenstein, A.: Der Kalium-Natrium-Austausch als Energieprinzip in Muskel and Nerv. Berlin-Göttingen-Heidelberg: Springer 1955.
Fleisher, J. H., J. P. Corriganand J. W. Howard: Potentiation of the response of frog rectus muscle to acetylcholine by isopropyl methyl phosphonofluoridate and its modification by pyridine-2-aldoxime methiodide. Brit. J. Pharmacol. 13, 291–295 (1958).
Fleisher, J. H., J. Hansa, P. J. Killosand C. S. Harrison: Effects of 1,1’trimethylene bis (4-formylpyridinium bromide) dioxime (EA 1814) on cholinesterase activity and neuromuscular block in rats following poisoning with sarin and DFP. J. Pharmacol. exp. Ther. 130, 461–468 (1960).
Fraser, T. R.: An experimental research on the antagonism between the actions of physostigma and atropia. Trans. roy. Soc. Edinb. 26, 529–713 (1870).
Fredrirsson, T.: Studies on the percutaneous absorption of swill and two allied organo-phosphorus cholinesterase inhibitors. Acta derm.-venereol. (Stockh.) Suppl. 41, 1–83 (1958).
Freedman, A. M., P. D. Bales, A. Willisand H. E Hmswscn: Experimental production of electrical major convulsive patterns. Amer. J. Physiol. 156, 117–124 (1949).
Freedmann, A. M. and H. E. Humwicn: DFP: site of injection and variation in response. Amer. J. Physiol. 156, 125–128 (1949).
Freeman, G., and M. A. Epstein: Therapeutic factors in survival after lethal cholinesterase inhibition by phosphorus insecticides. New Engl. J. Med. 253, 266–271 (1955).
Gesell, R., and J. S. Frey: Temporal summation of stimuli studied with the aid of anti -cholinesterases. Amer. J. Physiol. 160, 375–384 (1950).
Gesell, R., and E. T. Hansen: Eserine, acetylcholine, atrophie and nervous integration. Amer. J. Physiol. 139, 371–385 (1943).
Ghosn, R., and J. F. Newman: A new group of organophosphorus pesticides. Chem. Ind. 29 January 1955, 118.
Gioia, A., and C. Morpurgo: Effect of inhibitors of choline acetylation on acetylcholine output and motility in response to anticholinesterases and to distension of the lumen of isolated guinea-pig ileum. Brit. J. Pharmacol. 13, 467–470 (1958).
Goldstein, A.: The mechanism of enzyme-inhibitor-substrate reactions. Illustrated by the cholinesterase-physostigmine-acetylcholine system. J. gen. Physiol. 27, 529–580 (1944).
Gordon, A. S., and C. W. Frye: Large doses of atropine; low toxicity and effectiveness in anticholinesterase intoxication. J. Amer. med. Ass. 159, 1181–1184 (1955).
Gosselin, R. E., J. D. Gaboureland J. H. Wills: The fate of atrophie in man. Clin. Pharmacol. Therap. 1, 597–603 (1960).
Green, A. L., G. L. Sainsbury, B. Savilleand M. Stansfield: The reactivity of some active nucleophilic reagents with organophosphorus anticholinesterases. J. them. Soc. 1958, 1583 —1587.
Green, A., and B. Saville: The reaction of oximes with isopropyl methylphosphonofluoridate (sarin). J. them. Soc. 1956, 3887–3892.
Green, R. E., E. A. Mckayand S. Krop: The action of DFP on the caliber of the bronchial tree in isolated lungs. Fed. Proc. 6, 334 (1947).
Griesemer, R. D., I. H. Blankand E. Gould: The penetration of an anticholinesterase agent (sarin) into skin. III. A method for studying the rate of penetration into the skin of the living rabbit. J. invest. Derm. 31, 255–258 (1958).
Grob, D.: Uses and hazards of the organic phosphate anticholinesterase compounds. Ann. intern. Med. 32, 1229–1234 (1950).
Grob, D.: The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. Arch. intern. Med. 98, 221–239 (1956).
Grob, D., W. L. Garlickand A. Mcg. Harvey: The toxic effects in man of the anticholinesterase insecticide parathion (p-nitropenyl diethyl thionophosphate). Bull. Johns Hopk. Hosp. 87, 106–129 (1950).
Grob, D., and A. Mcg. Harvey: Observations on the effects of tetraethyl pyrophosphate (TEPP) in man, and on its use in the treatment of myasthenia gravis. Bull. Johns Hopk. Hosp. 84, 532–567 (1949).
Grob, D., and A. Mcg.: The effects and treatment of nerve gas poisoning. Amer. J. Med. 14, 52–63 (1953).
Grob, D., and A. Mcg., O. R. Lanoworthyand J. L. Lilienthal, jr.: The administration of diisopropyl fluoro-phosphate (DFP) to man. III. Effect on the central nervous system with special reference to the electrical activity of the brain. Bull. Johns Hopk. Hosp. 81, 257–266 (1947).
Grob, D., and R. J. Johns: Use of oximes in the treatment of intoxication by anticholinesterase compounds in normal subjects. Amer. J. Med. 24, 497–511 (1958).
Grob, D., J. L. Lilienthal, jr., A. M. Harveyand B. F. Jones: The administration of diisopropyl fluorophosphate (DFP) to man. I. Effect on plasma and erythrocyte cholinesterase; general systemic effects; use in study of hepatic function and erythropoiesis; and some properties of plasma cholinesterase. Bull. Johns Hopk. Hosp. 81, 217–244 (1947).
Groblewski, G. E., B. P. Mcnamaraand J. H. Wills: Stimulation of denervated muscle by DFP and related compounds. J. Pharmacol. 118, 116–122 (1956).
Guyton, A. C., and M. A. Macdonald: Physiology of botulinus toxin. Arch. Neurol. Psychiat. (Chicago) 57, 578–592 (1947).
Gyermek, L.: Studies on cholinergie blocking substances. VII. Correlations between anticholinergic and cholinesterase-blocking effects. Acta Physiol. 8, 43–48 (1955a).
Gyermek, L.: Studies on cholinergie blocking substances. VIII. Pharmacological actions of certain poly-methylene bis-and azapentylene bis-pyrrolidine and piperidine derivatives. Acta Physiol. 8, 49–60 (1955b).
Haase, J., D. Lücke, F. Scheler, R. Schütz, B. Mihlbergu. W. Koll: Die Wirkung von Cholinesterasegiften auf Reflexsysteme der tiefspinalen Katze. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 232, 274–276 (1957).
Hackley, B. E., jr., R. Plapinger, M. Stolbergand T. Wagner-Jauregg: Acceleration of the hydrolysis of organic fluorophosphates and fluorophosphonates with hydroxamic acids. J. Amer. them. Soc. 77, 3651–3653 (1955).
Haley, T. J.: Intracerebral injection of neostigmine and eserine in conscious mice. J. Amer. pharm. Ass. sci. Ed. 46, 252–254 (1957).
Hazard, R., E. Corteggianiand J. Cheymol: Différenciation par la novocaine des effets dépresseurs de l’ésérine sur le coeur et de son action sensibilisante à l’acétylcholine. C. R. Acad. Sci. (Paris) 220, 627–628 (1945).
Heubner, W.: Pharmakologisches und Chemisches über das Physostigmin. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 53, 313–330 (1905).
Heymans, C., and J. Jacob: Sur la pharmacologie du di-isopropyl-fluorophosphonate (D.F.P.) et le rôle des cholinestérases. Arch. int. Pharmacodyn. 74, 233–252 (1947).
Heymans, C., R. Pannierand R. Verbeke: Influence des anticholinestérases prostigmine, ésérine et diisopropylfluorophosphate, et de l’atropine, sur la transmission centrale et périphérique des excitations nerveuses. Arch. int. Pharmacodyn. 72, 405–429 (1946).
Heymans, C., A. Pochetand H. van Houtte: Contributions à la pharmacologie du sarin et du tabun. Arch. int. Pharmacodyn. 104, 293–332 (1956).
Hmiwldh, H. E., C. F. Essig, J. L. Hampson, P. D. Balesand A. M. Freedman: Effect of trimethadione (tridione) and other drugs on convulsions caused by diisopropyl fluoro-phosphate (DFP). Amer. J. Psychiat. 106, 816–820 (1950).
Heymans, C., and F. Rinaldi: The antiparkinson activity of benactyzine. Arch. int. Pharmacodyn. 110, 119–127 (1957).
Hobbiger, F.: The action of carbamic esters and tetraethylpyrophosphate on normal and curarized frog rectus muscle. Brit. J. Pharmacol. 5, 37–48 (1950).
Hobbiger, F.: Inhibition of cholinesterases by irreversible inhibitors in vitro and in vivo. Brit. J. Pharmacol. 6, 21–30 (1951).
Hobbiger, F., and P. W. Sadler: Protection by oximes of bis-pyridinium ions against lethal DFP poisoning Nature (Lond.) 182, 1672–1673 (1958).
Hobbiger, F., and P. W. Sadler: Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. Brit. J. Pharmacol. 14, 192–201 (1959).
Hodge, H. C., and J. H. Sterner: The skin absorption of triorthocresyl phosphate as shown by radioactive phosphorus. J. Pharmacol. 79, 225–234 (1943).
Holmes, J. H., and M. D. Gaon: Observations on acute and multiple exposures to anti-cholinesterase agents. Trans. Amer. clin. climat. Ass. 68, 86–101 (1956).
Holmes, J. H., E. J. Kinzerand R. W. Hibbert: Parathion poisoning case report. Rocky Mtn. med. J. 54, 1022–1031 (1957).
Holmes, R.: The physiological mechanisms involved in poisoning with anticholinesterases. Proc. roy. Soc. Med. 46, 799–800 (1953).
Holmstedt, B.: Synthesis and pharmacology of dimethylamidoethoxy-phosphoryl cyanide (Tabun) together with a description of some allied anticholinesterase compounds containing the N—P bond. Acta physiol. scand. suppl. 90, 1–120 (1951).
Holmstedt, B., and C. R. Skoglund: The action on spinal reflexes of dimethylamidoethoxy-phosphoryl cyanide, “Tabun,” a cholinesterase inhibitor. Acta physiol. scand. 29, 410–427 (1953).
Hornykiewicz, O., and W. Kobinger: Über den Einfluß von Eserin, Tetraäthylpyrophosphat (TEPP) und Neostigmin auf den Blutdruck und die pressorischen Carotissinusreflexe der Ratte. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 228, 493–500 (1956).
Hyde, J., S. Beckettand E. Gellhorn: Acetylcholine and convulsive activity. J. Neurophysiol. 12, 17–27 (1949).
Jaco, N. T., and D. R. Wood: The interaction between procaine, cocaine, adrenaline and prostigmine on skeletal muscle. J. Pharmacol. 82, 63–73 (1944).
Jandorf, B. J., 1951, quotedby W. H. Summerson: Progress in the biochemical treatment of nerve gas poisoning. U.S. armed Forces chem. J. 9, No. 1, 24–26 (1955).
Jandorf, B. J.: Chemical reactions of nerve gases in neutral solution. I. Reactions with hydroxylamine. J. Amer. them. Soc. 78, 3686–3691 (1956).
Jandorf, B. J., T. Wagner-Jauregg, J. J. O’neill and M. A. Stolberg: The reaction of phosphorus-containing enzyme inactivators with phenols and polyphenols. J. Amer. them. Soc. 74, 1521–1523 (1952).
Johns, R. J., and H. E. Hmlwich: A central action of some antihistamines. Amer. J. Psychiat. 107, 367–373 (1950).
Johnson, R. P., A. J. Goldand G. Freeman: Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following parathion and sarin intoxication. Amer. J. Physiol. 192, 581–584 (1958).
Kagan, Y. S.: Experimental data on the therapy of intoxication with the organophosphorus insecticide thiophos (in Russian). Farmakol. i Toksikol. 19, No. 2, 49–52 (1956).
Kalow, W., and M. O. Maykut: The interaction between cholinesterases and a series of local anesthetics. J. Pharmacol. exp. Ther. 116, 418–432 (1956).
Kalser, S. C., J. H. Wills, J. D. Gabourel, R. E. Gosselinand C. F. Epes: Further studies of the excretion of atropine-alpha-C14. J. Pharmacol. exp. Ther. 121, 449–456 (1957).
Karzcmar, A. G.: Antagonism between a bis-quaternary oxamide, WIN 8078, and depolarizing and competitive blocking agents. J. Pharmacol. exp. Ther. 119, 39–47 (1957).
Karzcmar, A. G., and J. P. Long: Relationship between peripheral cholinolytic potency and tetraethylpyrophosphate antagonism of a series of atropine substitutes. J. Pharmacol. exp. Ther. 123, 230–237 (1958).
Kilpatrick, M., and M. L. Kilpatrick: The hydrolysis of diisopropyl fluorophosphate. J. phys. coll. Chem. 53, 1371–1385 (1949).
King, T. O., and E. Poulsen: The action of an aldoxime (2-pyridine aldoxime methiodide) on acute alkylphosphate poisoning in mice. Arch. int. Pharmacodyn. 114, 118–121 (1958).
Kirschner, L. B., and W. E. Stone: Action of inhibitors at the myoneural junction. J. gen. Physiol. 34, 821–834 (1951).
Kleinwäciter, L.: Beobachtung über die Wirkung des Calabar-Extracts gegen Atropin-Vergiftung. Berl. klin. Wschr. 1, 369–371 (1864).
Kobert, R.: Über die Deutung der Muscarinwirkung am Herzen. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 20, 92–115 (1886).
Koelle, G. B.: Protection of cholinesterase against irreversible inactivation by DFP in vitro. J. Pharmacol. exp. Ther. 88, 232–237 (1946).
Koelle, G. B.: Histochemical demonstration of reactivation of acetylcholinesterase in vivo. Science 125, 1195–1196 (1957).
Kondritzer, A. A.: Chemistry, detection and decontamination of nerve gases. U.S. armed Forces med. J. 7, 791–796 (1956).
Kondritzer, A. A., W. H. Mayerand P. Zvirblis: Removal of satin from skin and eyes. Arch. industr. Hlth. 20, 50–52 (1959).
Koster, R.: Synergisms and antagonisms between physostigmine and di-isopropyl fluoro-phosphate in cats. J. Pharmacol. exp. Ther. 88, 39–46 (1946).
Krivoy, W. A., E. R. Hartand A. S. Marrazzi: Further analysis of the actions of DFP and curare on the respiratory center. J. Pharmacol. exp. Ther. 103, 351 (1951).
Krivoy, W. A., and J. H. Wills: Adaptation to constant concentrations of acetylcholine. J. Pharmacol. exp. Ther. 116, 220–226 (1956).
Krop, S., and A. M. Kunkel: Observations on the pharmacology of the anticholinesterases satin and tabun. Proc. Soc. exp. Biol. (N. Y.) 86, 530–533 (1954).
Kumagai, H., S. Ebashiand F. Taxeda: Studies on choline acetylase (in Japanese). Folia pharmacol. jap. 49, 477–484 (1953).
Kunkel, A. M., A H Oikemusand J. H. Wills: Studies on bisquaternary aliphatic compounds. Fed. Proc. 11, 365 (1952).
Kunkel, A. M., J. H. Willsand J. S. Monier: Antagonists to neuromuscular block produced by satin. Proc. Soc. exp. Biol. (N. Y.) 92, 529–532 (1956).
Kunkel, A. M., and A. H. Oikemus: Effect of a quaternary derivative of atropine, N-benzyl atropinium chloride. Proc. Soc. exp. Biol. (N. Y.) 96, 791–794 (1957).
Larsson, L.: The alkaline hydrolysis of isopropoxy-methyl-phosphoryl fluoride (satin) and some analogues. Acta Chem. scand. 11, 1131–1142 (1957).
Larsson, L.: A kinetic study of the reaction of isopropoxy-methyl-phosphoryl fluoride (satin) with hydrogen peroxide. Acta chem. scand. 12, 723–730 (1958a).
Larsson, L.: The alkaline hydrolysis of two satin analogues and of tabun. Acta chem. scand. 12, 783–785 (1958b)
Larsson, L.: The catalytic effect of Cr042-, Mo042- and W042- on the hydrolysis of isopropoxy-methylphosphoryl fluoride (satin). Acta chem. scand. 12, 1226–1230 (1958c).
Larsson, L.: Studies on the chemical reactivity of organic phosphorus compounds. Svensk. kern. Tidskr. 70, 405–427 (1958d).
Loew, E. R., and A. Micetich: Adrenergic blocking drugs. I. Comparisons of effectiveness in decreasing epinephrine toxicity in mice. J. Pharmacol. exp. Ther. 93, 434 443 (1948a).
Loew, E. R., and A. Micetich: Adrenergic blocking drugs. II. Antagonism of histamine and epinephrine with N-(2-haloalkyl)-1-naphthalene-methylamine derivatives. J. Pharmacol. exp. Ther. 94, 339–349 (1948b).
Loew, E. R., and A. Micetich: Adrenergic blocking drugs. IV. Antagonism of epinephrine and histamine with 2-(2-biphenyloxy) 2’-chlorodiethylamine derivatives. J. Pharmacol. exp. Ther. 95, 448–454 (1949).
Loewi, O., u. E. Navratil: Über humorale Übertragbarkeit der Herznervenwirkung. XI. Über den Mechanismus von Physostigmin and Ergotamine. Pflügers Arch. ges. Physiol. 214, 689–696 (1926).
Lordi, N. G., and J. Epstein: Kinetics and mechanism of chlorination of triethyl-phosphoro-thiolate in dilute aqueous media at 25°. J. Amer. chem. Soc. 80, 509–515 (1958).
LundiOlm, L.: The effect of DFP on respiration, blood pressure and muscular function in the rabbit. Acta physiol. scand. 16, 345–366 (1949).
Macintosh, F. C., R. I. Birksand P. B. Sastry: Pharmacological inhibition of acetylcholine synthesis. Nature (Lond.) 178, 1181 (1956).
Mcnamara, B. P., G. B. Koelleand A. Gilman: The treatment of DFP poisoning in rabbits. J. Pharmacol. exp. Ther. 88, 27–33 (1946).
Mcnamara, B. P., E. F. Murtha, A. D. Bergner, E. M. Robinson, C. W. Benderand J. H. Wills: Studies on the mechanism of action of DFP and TEPP. J. Pharmacol. exp. Ther. 110, 232–240 (1954).
Meeter, E.: The relation between end-plate depolarization and the repetitive response elicited in the isolated rat phrenic nerve-diaphragm preparation by DFP. J. Physiol. (Lond.) 144, 38–51 (1958).
Metz, B.: Brain acetylcholinesterase and a respiratory reflex. Amer. J. Physiol. 192, 101–105 (1958).
Meyer, F.: Untersuchungen über 17 neue Dialkyl-dihalogenvinyl-und Tetrahalogenäthylphosphate. Thesis, Hamburg University (1953).
Miller, F. R.: Effects of eserine and acetylcholine on the respiratory centers and hypoglossal nuclei. Canad. J. Res. E. 27, 374–386 (1949).
Modell, W., S. Krop, P. Hrrcucockand W. F. Riker, jr.: General systemic actions of di-isopropyl fluorophosphate (DFP) in cats. J. Pharmacol. exp. Ther. 87, 400 413 (1946).
Moruzzi, G., and H. W. Magoun: Brain stem reticular formation and activation of the EEG. Electroenceph. clin. Neurophysiol. 1, 455–473 (1949).
Murphy, S. D., and K. P. Dubois: Enzymatic conversion of the dimethoxy ester of benzotriazine dithiophosphoric acid to an anticholinesterase agent. J. Pharmacol. exp. Ther. 119, 572–583 (1957).
Nacemansohn, D.: Chemical mechanism of nerve activity. Ann N Y Acad. Sci. 47, 395–428 (1946).
Nathan, P., M. H. Aprisonand H. E. Himwrcu: A comparison of the effects of atropine with those of several central nervous system stimulants on rabbits exhibiting forced circling following the intracarotid injection of diisopropyl fluorophosphate. Confin. neurol. (Basel) 15, 1–10 (1955).
Nickerson, M., and G. M. Nomaguchi: Adrenergic blocking action of phenoxyethyl analogues of dibenamine J Pharmacol. exp. Ther. 101, 379–396 (1951).
Oberst, F. W., R. S. Ross, M. K. Christensen, J. W. Crook, P. Cresthulland C. W. Umland, II: Resuscitation of dogs poisoned by inhalation of the nerve gas GB. Mil. Med. 119, 377–386 (1956).
O’brien, R. D.. and A. N. Davison: Antagonists to schradan poisoning in mice. Canad. J. Biochem. 36, 1203–1210 (1958).
Oliver, G., and E. A. Schäfer: The physiological effects of extracts of the suprarenal capsules. J. Physiol. (Lond.) 18, 230–276 (1895).
Parkes, M. W., and P. Sacra: Protection against the toxicity of cholinesterase inhibitors by acetylcholine antagonists. Brit. J. Pharmacol. 9, 299–305 (1954).
Paton. W. D. M., and E. J. Zalmis: The methonium compounds. Pharmacol. Rev. 4, 219–253 (1952).
Paulet, G.: Nouvelle contribution à l’étude de l’action pharmacologique du tétraéthylpyrophosphate (TEPP). Arch. int. Pharmacodyn. 97, 157–185 (1954).
Paulet, G.: Activité cholinestérasique et fonctionnement des centres respiratoires. J. Physiol. Path. gén. 48, 915–936 (1956).
Petry, H.: Polyneuritis durch E 605. Zbl. Arbeitsmed. 1, 86–89 (1951).
Petty, C. S.: Organic phosphate insecticide poisoning. Amer. J. Med. 24, 467–470 (1958).
Poohet, A.: Action des neurotoxiques phosphorés sur la respiration. Acta belg. mil. 110, 153–165 (1957).
Polet, H.,and A. F. de Schaepdryver: Effect of sarin on the cardio-inhibitory vasomotor and respiratory centers of the isolated head in dogs. Arch. int. Pharmacodyn. 118, 231–247 (1959).
Rajapurkar, M. V., and G. B. Koelle: Reactivation of DFP-inactivated acetylcholinesterase by monoisonitroso-acetone (MINA) and diacetylmonoxime (DAM) in vivo. J. Pharmacol. exp. Ther. 123, 247–253 (1958).
Reisberg, R. B.: Properties and biological significance of choline acetylase. Yale J. Biol. Med. 29, 403–435 (1957).
Riker, W. F., jr.: and W. C. Wescoe: The direct action of prostigmine on skeletal muscle; its relationship to the choline esters. J. Pharmacol. exp. Ther. 88, 58–66 (1946).
Rinaldi, F., and H. E. Hnmwzcn: Alerting responses and actions of atropine and cholinergic drugs. Arch. Neurol. Psychiat. (Chicago) 73, 387–395 (1955a).
Rinaldi, F., and H. E.,Cholinergie mechanism involved in function of mesodiencephalic activating system. Arch. Neurol. Psychiat. (Chicago) 73, 396 402 (1955b).
Rinaldi, F.: Drugs affecting psychotic behavior and function of mesodiencephalic activating system. Dis. nerv. Syst. 16, 133–141 (1955c).
Roepke, M. H.: A study of choline esterase. J. Pharmacol. exp. Ther. 59, 264–276 (1937).
Rosenberg, P., and J. M. CooN: Increase of hexobarbital sleeping time by certain anticholinesterases. Proc. Soc. exp. Biol. (N. Y.) 98, 650–652 (1958).
Rosenberg, P., and J. M. CooN: Nikethamide, nicotinamide and some related compounds in anticholinesterase poisoning. J. Pharmacol. exp. Ther. 128, 289–298 (1960).
Sarai, F., H. DalRI, W. D. Erdmannu. G. Schmidt: Úber die Atemlähmung durch Parathion oder Paraoxon und ihre antagonistische BeeinfluBbarkeit. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 234, 210–219 (1958).
Salerno, P. R., and J. M. Coon: A pharmacologic comparison of hexaethyl tetraphosphate (HETP) and tetraethyl pyrophosphate (TEPP) with physostigmine, neostigmine and DEP. J. Pharmacol. exp. Ther. 95, 240–255 (1949).
Sallé, J.: Etude pharmacologique sur le thiophosphate de diéthyle et de paranitrophényle (Thiophos). Arch. int. Pharmacodyn. 82, 181–191 (1950).
Schaeffer, K.-P.: Wirkung von E 605 und anderen Esteraseblockern auf Körperstell-und -haltereflexe. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak 226, 505–517 (1955).
Schiff, M., W. G. Esmondand H. E. Himwich: Forced circling movements (adversive syndrome). Correction with dimenhydrinate (“Dramamine”). Arch. Otolaryng. (Chicago) 51, 672–677 (1950).
Schriftman, H., and A. A. Kondritzer: Absorption of atropine from muscle. Amer. J. Physiol. 191, 591–594 (1957).
Schweitzer, A., and S. Wright: The action of eserine and related compounds and of acetylcholine on the central nervous system. J. Physiol. (Lond.) 89, 165–197 (1937a).
Schweitzer, A., and S. Wright: Further observations on the action of acetylcholine, prostigmine and related substances on the knee jerk. J. Physiol. (Lond.) 89, 381 402 (1937b).
Secker, J.: The humoral control of the secretion by the submaxillary gland of the cat following chorda stimulation. J. Physiol. (Lond.) 81, 81–92 (1934).
Seifter, J., and D. H. Baeder: Partially depolymerized hyaluronic acid (PDHA) as a spreading agent. Proc. Soc. exp. Biol. (N. Y.) 85, 160–162 (1954).
Shelley, H.: The inhibition of acetylcholine synthesis in guinea-pig brain slices by eserine and neostigmine. J. Physiol. (Lund.) 131, 329–340 (1956).
Smith, M. I., and R. D. Lillie: Histopathology of triorthocresyl phosphate poisoning: etiology of so-called ginger-paralysis. Arch. Neurol. Psychiat. (Chicago) 26, 976–992 (1931).
Steinberg, G. M., and J. Bolger: N-hydroxy aryl carbamates. A class of hydroxamic acids which form stable phosphorylated and sulfated derivatives. J. org. Chem. 21, 660–662 (1956).
Stevenson, J. W., and G. T. Grrvnr: The effect of botulinum toxin on the bacterial acetylation of choline. Atti VI. Congr. int. Microbiol. 4, 133–134 (1953).
Stewart, G. N., and J. M. Rogoff: The action of drugs upon the output of epinephrin from the adrenals. VII. Physostigmine. J. Pharmacol. exp. Ther. 17, 227–248 (1921).
Stewart, W. C.: Accumulation of acetylcholine in brain and blood of animals poisoned with cholinesterase inhibitors. Brit. J. Pharmacol. 7, 270–276 (1952).
Stolberg, M. A., and W. A. Mosher: Rates of reaction of vicinally substituted hydroxamic acids with isopropyl methylphosphonofluoridate (sarin). J. Amer. them. Soc. 79, 2618 —2620 (1957).
Stone, C. A., and E. R. Loew: Adrenergic blocking drugs. III. Effects of 2-halogenated ethyl-amines on pressor responses to epinephrine, nicotine and adrenergic nervous reflexes. J. Pharmacol. exp. Ther. 94, 350–358 (1948).
Stovner, J.: Effect of choline on the action of anticholinesterases. Acta pharm. tox. (Kbh.) 12, 175–186 (1956).
Straus, O. H., and A. J. Goldstein: Zone behavior of enzymes. Illustrated by the effect of dissociation constant and dilution on the system cholinesterase-physostigmine. J. gen. Physiol. 26, 559–585 (1943).
Stumpf, C.: Pharmakologie des aszendierenden reticulären Systems. Wien. klin. Wschr. 69, 298–303 (1957).
Swidler, R., R. E. Plapingerand G. M. Steinberg: The kinetics of the reaction of isopropyl methylphosphonofluoridate (sarin) with substituted benzohydroxamic acids. II. J. Amer. them. Soc. 81, 3271–3274 (1959).
Swidler, R., and G. M. Steinberg: The kinetics of the reaction of isopropyl methylphosphonofluoridate (sarin) with benzohydroxamic acid. J. Amer. chem. Soc. 78, 3594–3598 (1956).
Tammelin, L.-E.: Methyl-fluoro-phosphorylcholines. Two synthetic cholinergic drugs and their tertiary homologues. Acta chem. scand. 11, 859–865 (1957a).
Tammelin, L.-E.: Dialkoxy-phosphorylthiocholines, alkoxy-methyl-phosphorylthiocholines and analogous choline esters. Syntheses, pKa, of tertiary homologues and cholinesterase inhibition. Acta chem. scand. 11, 1340–1349 (1957b).
Tammelin, L.-E.: Organophosphorylcholines and cholinesterases. Ark. Kemi 12, 287–298 (1958a).
Tammeltn, L.-E.: Choline esters. Substrates and inhibitors of cholinesterases. Svensk. kem. T. 70, 157–181 (1958b).
Thesleff, S.: Neuromuscular block caused by acetylcholine. Nature (Lond.) 175, 594–595 (1955).
Todrick, A.: The inhibition of cholinesterases by antagonists of acetylcholine and histamine. Brit. J. Pharmacol. 9, 76–83 (1954).
Turpaev, T. M., and T. G. Putinceva: Compensatory reactions of the sympathetic nervous system in asphyxia due to bronchial spasm (in Russian). Fiziol. Z. (Mosk.) 41, 71–77 (1955).
Varagic, V.: The action of eserine on the blood pressure of the rat. Brit. J. Pharmacol. 10, 349–353 (1955).
Verbeke, R.: Nouvelles contributions à la pharmacologie du di-isopropylfluorophosphonate (DFP). Arch. int. Pharmacodyn. 79, 1–31 (1949).
Wagner-Jauregg, T., and B. E. Hackleyjr.: Model reactions of phosphorus-containing enzyme inactivators. III. Interaction of imidazole, pyridine and some of their derivatives with dialkyl halogeno-phosphates. J. Amer. chem. Soc. 75, 2125–2130 (1953).
Wagner-Jauregg, T., and B. E. Hackleyjr.,T. A. Lies, O. O. Owensand R. Proper: Model reactions of phosphorus-containing enzyme inactivators. VI. The catalytic activity of certain metal salts and chelates in the hydrolysis of diisopropyl fluorophosphate. J. Amer. chem. Soc. 77, 922–929 (1955).
Wagner-Jauregg, T., J. J. O’neill and W. H. Summerson: The reaction of phosphorus-containing enzyme inhibitors with amines and amino acid derivatives. J. Amer. them. Soc. 73, 5202–5206 (1951).
Wescoe, W. C., R. E. Green, B. P. Mcnamaraand S. Krop: The influence of atropine and scopolamine on the central effects of DFP. J. Pharmacol. exp. Ther. 92, 63–72 (1948).
Wescoe, W. C., R. E. Green, B. P. Mcnamara: On the mechanism of the convulsant action of strychnine; the lack of atropine antagonism. J. Pharmacol. exp. Ther. 94, 78–84 (1948).
Wills, J. H.: Substitutes for and adjuncts to atropine in nerve gas poisoning U S armed Forces med. J. 6, 1329–1332 (1955).
Wills, J. H.: Recent studies of organic phosphate poisoning. Fed. Proc. 18, 1020–1025 (1959).
Wills, J. H., and H. L. Borison: Modification by sarin and antagonists of medullary respiratory activities. Fed. Proc. 18, 459 (1959).
Wills, J. H.,A. M. Kunkel, J. F. O’leary and A. H. Oikemus: Effect of 2-PAM on neuromuscular blockade induced by certain chemicals. Proc. Soc. exp. Biol. (N. Y.) 101, 196–197 (1959).
Wilson, I. B.: Acetylcholinesterase. XI. Reversibility of tetraethyl pyrophosphate inhibition. J. biol. Chem. 190, 111–117 (1951).
Wilson, I. B.: Acetylcholinesterase. XIII. Reactivation of alkyl phosphate-inhibited enzyme. J. biol. Chem. 199, 113–120 (1952).
Wilson, I. B., and F. Sondheimer: A specific antidote against lethal alkyl phosphate intoxication. V. Antidotal properties. Arch. Biochem. 69, 468–474 (1957).
Woon, J. R., P. F. Dickens, jr., J. RlzzoLoand M. W. Bayliss: Treatment of nerve-gas casualties. U.S. armed Forces med. J. 2, 1609–1617 (1951).
Weight, P. G.: An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. J. Physiol. (Lond.) 126, 52–70 (1954).
Zawadzki, B.: The site of origin of acetylcholine (ACh) liberated from the motor nerve endings during stimulation (in Polish). Acta physiol. pol. 6, 15–32 (1955).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1963 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wills, J.H. (1963). Pharmacological Antagonists of the Anticholinesterase Agents. In: Koelle, G.B. (eds) Cholinesterases and Anticholinesterase Agents. Handbook of Experimental Pharmacology, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99875-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-99875-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99877-5
Online ISBN: 978-3-642-99875-1
eBook Packages: Springer Book Archive